Targeted drug therapy to overcome chemoresistance in triple-negative breast cancer M Kumari, PT Krishnamurthy, P Sola Current cancer drug targets 20 (8), 559-572, 2020 | 17 | 2020 |
DR-5 and DLL-4 mAb functionalized SLNs of gamma-secretase inhibitors-An approach for TNBC treatment M Kumari, PT Krishnamurthy, P Sola Advanced Pharmaceutical Bulletin 11 (4), 618, 2021 | 12 | 2021 |
Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management P Sola, P Krishnamurthy, PK Chintamaneni, SKSS Pindiprolu, M Kumari Expert Opinion on Drug Delivery 17 (8), 1119-1132, 2020 | 12 | 2020 |
Neuroprotective approaches to halt Parkinson's disease progression PT Krishnamurthy, M Kumari, G Byran, HV Gangadharappa, ... Neurochemistry International 158, 105380, 2022 | 10 | 2022 |
Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics M Kumari, A Acharya, PT Krishnamurthy Beilstein Journal of Nanotechnology 14 (1), 912-926, 2023 | 5 | 2023 |
Comprehensive study to decline the burden of skin cancer M Kumari, ML Kaushik Int J Pharm Sci Drugs Res 10 (3), 111-17, 2018 | 1 | 2018 |
Polysorbate 80 surface modified SLNs of formoterol suppress SNCA gene and mitochondrial oxidative stress in mice model of Parkinson’s disease P Sola, KK Garikapati, PT Krishnamurthy, M Kumari Scientific Reports 13 (1), 19942, 2023 | | 2023 |
A Comprehensive Study on Progressive Hemifacial Atrophy. M Kumari, M Kaushik International Journal of Pharmacy & Life Sciences 9 (2), 2018 | | 2018 |
ANTIULCER ACTIVITY OF ETHANOLIC LEAVES EXTRACT OF MITRAGYNA PARVIFOLI ROXB. MK Madan L. Kaushik PARIPEX - INDIAN JOURNAL OF RESEARCH 6 (12), 421-423, 2017 | | 2017 |
A Review: The Global Burden of Breast Cancer M Kumari, ML Kaushik Research & Reviews: A Journal of Pharmacology 7 (2), 8-16, 2017 | | 2017 |
EVALUATION OF ANTIARTHRITIC POTENTIAL OF CURCUMA CAESIA ROXB RHIZOME Mamta Kumari, Madan L. Kaushik International Journal of Recent Scientific Research 8 (10), 21020-21024, 2017 | | 2017 |
Surface modified DLL4 and DR5 targeted solid lipid Nanoparticles of and# 947; secretase inhibitors for the effective treatment of triple negative breast cancer M Kumari Mysore, 0 | | |